Last reviewed · How we verify
NCT03942497
Clinical-pathological Characterization and Outcomes of Metastatic Urothelial Cancer in Latin America
trial in Recurrent/Metastatic Urothelial Cancers in 218 participants. Completed in 28 February 2022.
31 August 2021
Quick facts
| Lead sponsor | Latin American Cooperative Oncology Group |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 218 |
| Start date | 1 August 2019 |
| Primary completion | 31 August 2021 |
| Estimated completion | 28 February 2022 |
| Sites | 9 locations across Brazil |
Conditions studied
- Recurrent/Metastatic Urothelial Cancers — all drugs for Recurrent/Metastatic Urothelial Cancers →
Sponsor
Latin American Cooperative Oncology Group
Who can join
18 and older, any sex, with Recurrent/Metastatic Urothelial Cancers. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The LACOG 1518 study will characterize demographic and clinical-pathological profile of patients diagnosed with recurrent/ metastatic urothelial cancer in Latin America.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03942497
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Latin American Cooperative Oncology Group trials
Trials by the same sponsor.
- NCT07192991 — Neuroendocrine Carcinomas: Patient Journey And Treatment Outcomes In Latin America · not yet recruiting
- NCT06822543 — A Single Arm, Phase 2 Study of Datopotamab Deruxtecan, Carboplatin, and Pembrolizumab for Treatment-naive Brain Metastas · Phase 2 · recruiting
- NCT06527690 — Race Impact on Efficacy of Niraparib Plus Abiraterone Acetate and Prednisone in Patients With Homologous Repair Deficien · Phase 2 · withdrawn
- NCT06279442 — Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian Cohort · recruiting
- NCT06014580 — Molecular and Epidemiological Characteristics of Endometrial Cancer in Brazil · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03942497 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Latin American Cooperative Oncology Group
- Last refreshed: 12 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03942497.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing